StemCell Institute
7096.TPharmaceutical
In English · 4
Mon, Mar 3 · JST1 filing
16:005% STAKEStemCell Institute · NIHON TRIM CO., LTD. · 72.06% → 70.02%−2.04ppAll EDINET filings · 45
| Filed | Document | Source |
|---|---|---|
| 2026-08-14 | Material event report | S100YX4O |
| 2026-07-24 | Material event report | S100YS4L |
| 2026-07-02 | Amended material event reportAmends S100YI86 | S100YOG2 |
| 2026-06-25 | Material event report | S100YI86 |
| 2026-06-23 | Internal control report | S100YI7K |
| 2026-06-23 | CEO/CFO certification | S100YI73 |
| 2026-06-23 | Annual report | S100YI32 |
| 2025-12-01 | Share buyback report | S100X7WT |
| 2025-11-14 | CEO/CFO certification | S100X48Y |
| 2025-11-14 | Half-year report | S100X47U |
| 2025-11-04 | Share buyback report | S100WYGH |
| 2025-10-01 | Share buyback report | S100WSLV |
| 2025-06-26 | Material event report | S100W7JX |
| 2025-06-24 | Internal control report | S100W2WA |
| 2025-06-24 | CEO/CFO certification | S100W2W5 |
| 2025-06-24 | Annual report | S100W2VG |
| 2025-03-03 | Large shareholding reportRelated to S100V4SE | S100VBZZ |
| 2025-02-04 | Material event report | S100V6MM |
| 2025-02-04 | Large shareholding report | S100V4SE |
| 2025-02-04 | Large shareholding report | S100V6DD |
| 2024-11-14 | CEO/CFO certification | S100URSZ |
| 2024-11-14 | Half-year report | S100URSN |
| 2024-06-27 | Material event report | S100TWPQ |
| 2024-06-27 | Internal control report | S100TW7M |
| 2024-06-27 | CEO/CFO certification | S100TW6I |
| 2024-06-27 | Annual report | S100TW62 |
| 2024-04-26 | Material event report | S100TC4N |
| 2024-02-09 | Quarterly report | S100SSN1 |
| 2024-02-09 | CEO/CFO certification | S100SSNY |
| 2023-11-10 | CEO/CFO certification | S100S791 |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 4 financial reports not structured yet.